Pharmafile Logo
Pharmafocus logo
Advanced Search

hepatitis

Showing 4 posts of 19 posts found.

Novartis drops two drug candidates, takes $600 million hit

October 6, 2010
Research and Development Human Genome Sciences, Novartis, candidiasis, hepatitis

Novartis will incur a charge of nearly $600 million after it halted development of investigational drugs for hepatitis C and …

News
Andreotti

BMS to acquire ZymoGenetics

September 8, 2010
Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …

News

New Pegasys licence gives patients ‘second chance for a cure’

December 4, 2008
Sales and Marketing Roche, hepatitis

Hepatitis C patients who don't at first respond to treatment with Pegasys will now be able to receive the drug …

News

Call for universal Hepatitis B vaccination

August 22, 2008
Sales and Marketing hepatitis

The pharma industry has joined up with patient groups to petition for universal Hepatitis B immunisation for all children in …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026